Your browser doesn't support javascript.
loading
Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.
Pouliou, Evi; Xochelli, Aliki; Kanellis, George; Stalika, Evangelia; Sutton, Lesley-Ann; Navarro, Alba; Agathangelidis, Andreas; Dimosthenous, Kypros; Anagnostopoulos, Achilles; Patsouris, Efstratios; Korkolopoulou, Penelope; Sundstrom, Christer; Ghia, Paolo; Ponzoni, Maurilio; Sander, Birgitta; Campo, Elias; Rosenquist, Richard; Hadzidimitriou, Anastasia; Stamatopoulos, Kostas; Papadaki, Theodora.
Afiliação
  • Pouliou E; Hematopathology Department, Evangelismos Hospital, Athens, Greece; Department of Pathology, University of Athens School of Medicine, Athens, Greece.
  • Xochelli A; Institute of Applied Biosciences, Centre for Research and Technology Hellas (CERTH), Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Kanellis G; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Stalika E; Institute of Applied Biosciences, Centre for Research and Technology Hellas (CERTH), Thessaloniki, Greece.
  • Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Navarro A; Department of Pathology, Hospital Clinic, Barcelona, Spain; Institute of Biomedical Research August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Agathangelidis A; Division of Molecular Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute and Universita Vita-Salutte San Raffaele, Milan, Italy.
  • Dimosthenous K; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Anagnostopoulos A; Hematology Department and Hematopoietic Cell Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Patsouris E; Department of Pathology, University of Athens School of Medicine, Athens, Greece.
  • Korkolopoulou P; Department of Pathology, University of Athens School of Medicine, Athens, Greece.
  • Sundstrom C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Ghia P; Division of Molecular Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute and Universita Vita-Salutte San Raffaele, Milan, Italy.
  • Ponzoni M; Pathology Unit, San Raffaele Scientific Institute, Milan, Italy.
  • Sander B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden.
  • Campo E; Department of Pathology, Hospital Clinic, Barcelona, Spain; Institute of Biomedical Research August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Hadzidimitriou A; Institute of Applied Biosciences, Centre for Research and Technology Hellas (CERTH), Thessaloniki, Greece.
  • Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas (CERTH), Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Hematology Department and Hematopoietic Cell Transplantation Unit, G. Papanic
  • Papadaki T; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
Am J Pathol ; 187(7): 1454-1458, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28457696
ABSTRACT
To obtain insight into the ontogeny of mantle cell lymphoma (MCL), we assessed 206 patients from a morphological, immunohistochemical, and immunogenetic perspective. Our series included nodal (n = 151), extranodal (n = 28), and primary splenic (n = 27) MCL cases. Skewing of the immunoglobulin heavy variable (IGHV) gene repertoire was noted, with only four IGHV genes accounting for 46% of cases and approximately 70% of cases (107/154) bearing an imprint of somatic hypermutation (SHM) ranging from minimal to pronounced. Interestingly, a distinctive immunophenotypic and immunogenetic profile was identified for primary splenic MCL, which was enriched for DBA.44-positive cases (P < 0.001) and used the IGHV1-8 gene more frequently (P = 0.02) compared to nodal or extranodal cases, alluding to distinct immunopathogenetic and antigen selection processes. Expression of CD27 (considered a marker of activated B cells) was generally dissociated from SHM and was more prevalent in cases with no or minimal/borderline SHM. These findings support the idea that antigen drive is relevant for most MCL cases, although the specific antigens and the precise location of affinity maturation remain to be elucidated. Moreover, they raise the intriguing hypothesis of multiple cellular origins for MCL.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Biomarcadores Tumorais / Linfoma de Célula do Manto / Imunogenética Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Biomarcadores Tumorais / Linfoma de Célula do Manto / Imunogenética Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article